Zi‐Niu Ding

662 total citations
45 papers, 391 citations indexed

About

Zi‐Niu Ding is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Zi‐Niu Ding has authored 45 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Epidemiology and 16 papers in Hepatology. Recurrent topics in Zi‐Niu Ding's work include Liver Disease Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). Zi‐Niu Ding is often cited by papers focused on Liver Disease Diagnosis and Treatment (13 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Hepatocellular Carcinoma Treatment and Prognosis (11 papers). Zi‐Niu Ding collaborates with scholars based in China and Sweden. Zi‐Niu Ding's co-authors include Zhao‐Ru Dong, Tao Li, Lun‐Jie Yan, Zhiqiang Chen, Dongxu Wang, Jian‐Guo Hong, Yu‐Chuan Yan, Hui Liu, Bao‐Wen Tian and Chuncheng Yang and has published in prestigious journals such as Cancer Research, Frontiers in Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

Zi‐Niu Ding

41 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zi‐Niu Ding China	11	179	112	110	75	72	45	391
Lun‐Jie Yan China	12	215 1.2×	121 1.1×	127 1.2×	99 1.3×	102 1.4×	47	494
Zhiqiang Chen China	11	199 1.1×	106 0.9×	110 1.0×	87 1.2×	109 1.5×	45	505
Rumi Itoyama Japan	12	176 1.0×	57 0.5×	68 0.6×	57 0.8×	58 0.8×	40	319
Go Ohira Japan	11	255 1.4×	67 0.6×	107 1.0×	61 0.8×	58 0.8×	53	413
Ryo Muranushi Japan	12	203 1.1×	95 0.8×	50 0.5×	35 0.5×	60 0.8×	41	341
Masahiro Shinoda Japan	12	162 0.9×	81 0.7×	87 0.8×	45 0.6×	53 0.7×	45	359
Ahmed Taki‐Eldin China	6	223 1.2×	60 0.5×	111 1.0×	43 0.6×	48 0.7×	11	415
Claudia Campani Italy	11	76 0.4×	111 1.0×	149 1.4×	58 0.8×	50 0.7×	41	301
Daiki Okamura Japan	10	165 0.9×	127 1.1×	98 0.9×	75 1.0×	181 2.5×	24	473
Rumi Matono Japan	14	206 1.2×	114 1.0×	192 1.7×	78 1.0×	81 1.1×	24	591

Countries citing papers authored by Zi‐Niu Ding

Since Specialization

Citations

This map shows the geographic impact of Zi‐Niu Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zi‐Niu Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zi‐Niu Ding more than expected).

Fields of papers citing papers by Zi‐Niu Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zi‐Niu Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zi‐Niu Ding. The network helps show where Zi‐Niu Ding may publish in the future.

Co-authorship network of co-authors of Zi‐Niu Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Zi‐Niu Ding. A scholar is included among the top collaborators of Zi‐Niu Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zi‐Niu Ding. Zi‐Niu Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ding, Zi‐Niu, Lun‐Jie Yan, Dongxu Wang, et al.. (2025). Hypoxia-Induced Creatine Uptake Reprograms Metabolism to Antagonize PARP1-Mediated Cell Death and Facilitate Tumor Progression in Hepatocellular Carcinoma. Cancer Research. 85(19). 3671–3688.

Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2025). An umbrella review of the association between dietary factors and hepatocellular carcinoma risk. Food & Function. 16(10). 3879–3890.

Liu, Shijia, Xiao Zhang, Lun‐Jie Yan, et al.. (2025). Comparison of tenofovir versus entecavir for preventing hepatocellular carcinoma in chronic hepatitis B patients: an umbrella review and meta-analysis. Journal of Cancer Research and Clinical Oncology. 151(2). 77–77.

Yan, Yu‐Chuan, Lijuan Shao, Xiong Chen, et al.. (2025). Targeting FAM111B attenuates mitophagy and increases the sensitivity to lenvatinib treatment by increasing MFN2 stability in hepatocellular carcinoma. Cell Death and Disease. 16(1). 645–645. 1 indexed citations

Tan, Siyu, Pan Guoqiang, Lun‐Jie Yan, et al.. (2024). DAP3 promotes mitochondrial activity and tumour progression in hepatocellular carcinoma by regulating MT-ND5 expression. Cell Death and Disease. 15(7). 540–540. 5 indexed citations

Liu, Hui, Lun‐Jie Yan, Zi‐Niu Ding, et al.. (2024). Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis. Journal of Gastroenterology and Hepatology. 39(8). 1464–1475. 2 indexed citations

Yan, Lun‐Jie, Yu‐Chuan Yan, Zi‐Niu Ding, et al.. (2023). Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose–response meta-analysis. European Journal of Cancer. 185. 150–163. 8 indexed citations

Li, Guangzhen, Pan Guoqiang, Lun‐Jie Yan, et al.. (2023). MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway. Cancer Cell International. 23(1). 188–188. 11 indexed citations

Ma, Yunlong, Chuncheng Yang, Lun‐Jie Yan, et al.. (2023). A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. Frontiers in Pharmacology. 14. 1101749–1101749. 7 indexed citations

10.

Yan, Lun‐Jie, Yu‐Chuan Yan, Zi‐Niu Ding, et al.. (2023). Regional and sex differences in the mortality risk associated with primary liver cancer in obesity: A systematic review and meta-analysis. Nutrition. 113. 112097–112097. 3 indexed citations

11.

Han, Cheng‐Long, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2022). The Predictive Potential of the Baseline C-Reactive Protein Levels for the Efficiency of Immune Checkpoint Inhibitors in Cancer Patients: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 827788–827788. 27 indexed citations

12.

Yan, Lun‐Jie, Zi‐Niu Ding, Jian‐Guo Hong, et al.. (2022). Efficacy and Safety of Aspirin for Prevention of Hepatocellular Carcinoma: An Updated Meta-analysis. Journal of Clinical and Translational Hepatology. 10(5). 835–846. 4 indexed citations

13.

Ding, Zi‐Niu, Jun-Shuai Xue, Lun‐Jie Yan, et al.. (2022). Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis. Journal of Cancer Research and Clinical Oncology. 149(5). 1993–2008. 13 indexed citations

14.

Ding, Zi‐Niu, Zhao‐Ru Dong, Zhiqiang Chen, et al.. (2021). Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis. Journal of Gastroenterology and Hepatology. 36(6). 1487–1496. 6 indexed citations

15.

Dong, Zhao‐Ru, Zhiqiang Chen, Xiaoyun Yang, et al.. (2021). RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival. Journal of Cancer. 12(13). 3827–3840. 10 indexed citations

16.

Ding, Zi‐Niu, Zhao‐Ru Dong, Zhiqiang Chen, et al.. (2021). Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis. Frontiers in Immunology. 12. 733530–733530. 26 indexed citations

17.

Yan, Lun‐Jie, Zi‐Niu Ding, Zhao‐Ru Dong, et al.. (2021). Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Hepatology International. 15(6). 1413–1420. 9 indexed citations

18.

Xue, Jun-Shuai, Hui Liu, Zi‐Niu Ding, et al.. (2021). Prognostic value of soluble programmed cell death-1 (sPD-1) and soluble programmed cell death ligand-1 (sPD-L1) for hepatocellular carcinoma: a systematic review and meta-analysis. Cancer Immunology Immunotherapy. 71(7). 1633–1644. 11 indexed citations

19.

Ding, Zi‐Niu, et al.. (2016). Punch biopsy guided by both colposcopy and HR-HPV status is more efficient for identification of immediate high-grade squamous intraepithelial lesion or worse among HPV-infected women with atypical squamous cells of undetermined significance. European Journal of Obstetrics & Gynecology and Reproductive Biology. 207. 32–36. 4 indexed citations

20.

Ding, Zi‐Niu, et al.. (2014). Xuemaitong granules attenuate carotid atherosclerosis by decreasing the expression of CD14+CD16+ monocytes, IL-6, TNF-α, and hsCRP. Genetics and Molecular Research. 13(3). 7519–7527. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact